These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2117336)

  • 41. Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism.
    Peterson CL; Thompson MA; Martin D; Nadler JV
    J Neurochem; 1995 Mar; 64(3):1152-60. PubMed ID: 7861146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CV-3988 - a specific antagonist of platelet activating factor (PAF).
    Terashita Z; Tsushima S; Yoshioka Y; Nomura H; Inada Y; Nishikawa K
    Life Sci; 1983 Apr; 32(17):1975-82. PubMed ID: 6403793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig.
    Anderson GP; Fennessy MR
    Agents Actions Suppl; 1988; 23():195-200. PubMed ID: 3140616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.
    Mounier C; Hatmi M; Faili A; Bon C; Vargaftig BB
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1460-7. PubMed ID: 8450479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
    Bozza PT; Payne JL; Goulet JL; Weller PF
    J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins.
    Kimura K; Shiota M; Mochizuki K; Ohta M; Sugano T
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):773-9. PubMed ID: 1317164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig.
    Lagente V; Desquand S; Hadvary P; Cirino M; Lellouch-Tubiana A; Lefort J; Vargaftig BB
    Br J Pharmacol; 1988 May; 94(1):27-36. PubMed ID: 3401641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance.
    Plaza V; Prat J; Rosellò J; Ballester E; Ramis I; Mullol J; Gelpí E; Vives-Corrons JL; Picado C
    Thorax; 1995 May; 50(5):490-6. PubMed ID: 7597660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastrin-releasing peptide stimulates glycoconjugate release from feline trachea.
    Lundgren JD; Baraniuk JN; Ostrowski NL; Kaliner MA; Shelhamer JH
    Am J Physiol; 1990 Feb; 258(2 Pt 1):L68-74. PubMed ID: 1689553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
    Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
    Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of a lipoxygenase inhibitor nordihydroguaiaretic acid on antagonism of leukotriene C4-induced contractions of isolated guinea-pig trachea.
    Shikada K; Yamamoto A; Tanaka S
    Prostaglandins; 1988 Oct; 36(4):533-46. PubMed ID: 3238005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle.
    Salari H; Schellenberg RR
    Pulm Pharmacol; 1991; 4(1):1-7. PubMed ID: 1804490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAF-induced conjunctivitis in the rabbit is mediated by peptido-leukotrienes.
    Muller A; Meynier F; Bonne C
    J Ocul Pharmacol; 1990; 6(3):227-32. PubMed ID: 1963192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Licofelone, a dual lipoxygenase-cyclooxygenase inhibitor, downregulates polymorphonuclear leukocyte and platelet function.
    Rotondo S; Dell'Elba G; Krauze-Brzósko K; Manarini S; Martelli N; Pecce R; Evangelista V; Cerletti C
    Eur J Pharmacol; 2002 Oct; 453(1):131-9. PubMed ID: 12393068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release.
    Metz SA
    Diabetes; 1986 Jul; 35(7):808-17. PubMed ID: 3087803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture.
    Wright DT; Adler KB; Akley NJ; Dailey LA; Friedman M
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):27-36. PubMed ID: 8048050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eosinophil VLA-4 binding to fibronectin augments bronchial narrowing through 5-lipoxygenase activation.
    Muñoz NM; Rabe KF; Neeley SP; Herrnreiter A; Zhu X; McAllister K; Mayer D; Magnussen H; Galens S; Leff AR
    Am J Physiol; 1996 Apr; 270(4 Pt 1):L587-94. PubMed ID: 8928818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.